Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate Cancer

SIMPLE SUMMARY: In almost all patients, the proliferation and growth of prostate cancer is driven by the androgen receptor. Given this critical role, inhibiting the androgen receptor is the standard of care following surgery or radiotherapy. However, the effectiveness of current anti-androgen therap...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: Ban, Fuqiang, Leblanc, Eric, Cavga, Ayse Derya, Huang, Chia-Chi Flora, Flory, Mark R., Zhang, Fan, Chang, Matthew E. K., Morin, Hélène, Lallous, Nada, Singh, Kriti, Gleave, Martin E., Mohammed, Hisham, Rennie, Paul S., Lack, Nathan A., Cherkasov, Artem
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8304761/
https://ncbi.nlm.nih.gov/pubmed/34298700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13143488
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky